🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, asserting the companies concealed alleged dangers that the drug posed to pediatric neurological development.

This legal action arrives four weeks after Donald Trump publicized an unverified association between taking acetaminophen - alternatively called acetaminophen - while pregnant and autism in offspring.

Paxton is suing the pharmaceutical giant, which previously sold the drug, the sole analgesic recommended for pregnant women, and Kenvue, which currently produces it.

In a statement, he said they "misled consumers by gaining financially from suffering and pushing pills regardless of the risks."

The company states there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening millions to increase profits," Paxton, from the Republican party, declared.

The company commented that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the health of women and children in America."

On its website, the company also stated it had "continuously evaluated the applicable studies and there is insufficient valid information that shows a proven link between consuming acetaminophen and autism spectrum disorder."

Associations speaking for physicians and medical practitioners concur.

The leading OB-GYN organization has declared paracetamol - the primary component in Tylenol - is among limited choices for pregnant women to address pain and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any trimester of pregnancy results in neurodevelopmental disorders in offspring," the group said.

The lawsuit mentions latest statements from the previous government in arguing the drug is potentially dangerous.

In recent weeks, the former president caused concern from public health officials when he advised pregnant women to "struggle intensely" not to take Tylenol when sick.

Federal regulators then published an announcement that physicians should contemplate reducing the consumption of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in young ones has not been established.

Health Secretary Kennedy, who manages the Food and Drug Administration, had vowed in April to conduct "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a limited time.

But authorities advised that identifying a unique factor of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a category of lifelong neurodivergence and impairment that impacts how persons perceive and interact with the surroundings, and is recognized using physician assessments.

In his court filing, Paxton - aligned with the former president who is running for federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "remove any promotional materials" that claims acetaminophen is safe for expectant mothers.

This legal action mirrors the complaints of a group of mothers and fathers of young ones with autism spectrum disorder and ADHD who took legal action against the manufacturers of acetaminophen in recently.

The court threw out the lawsuit, saying investigations from the plaintiffs' authorities was not conclusive.